Clinical Trial Update: CONTECI Program: A New Way to Control Peripheral Arterial Disease Using New Technologies [NA]

View source ↗

Summary

This is a completed update on the CONTECI program, describing a new technology-based approach to controlling peripheral arterial disease. The sponsor is Consorc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Snippet

Sponsor: Consorci Sanitari del Maresme | Conditions: Peripheral Arterial Disease, Personal Satisfaction | NA | Status: COMPLETED